ImmuCell Co. (NASDAQ:ICCC – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.96 and traded as high as $4.63. ImmuCell shares last traded at $4.41, with a volume of 24,463 shares.
ImmuCell Stock Performance
The stock has a fifty day simple moving average of $3.93 and a two-hundred day simple moving average of $3.96. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 3.11. The stock has a market cap of $39.30 million, a price-to-earnings ratio of -8.82 and a beta of 0.60.
ImmuCell Company Profile
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.
Read More
- Five stocks we like better than ImmuCell
- What is the Australian Securities Exchange (ASX)
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Invest in Biotech Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.
